Deutsche Bank lifted Hershey's price target ahead of second quarter results. RBC is short on Unimlever and has lowered its target after the group warned that high raw material prices were hitting margins and that it could be forced to raise prices to protect profits. After posting strong results, Vodafone gets a Buy from Goldman Sachs. Arvinas gets higher PT from Wedbush due to its collaboration with Pfizer.
Apple: Canaccord Genuity raises its target price from $165 to $175.
Arvinas : Wedbush lifts PT to $113 From $94 , maintains Outperform rating
Aviva: Company gets its only negative rating as Exane downgrades to underperfom from neutral
Biogen : Wedbush raises price target to $314 from $312, maintains neutral rating